Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$322M |
| 2 |
UnitedHealth
UNH
|
+$233M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
International Flavors & Fragrances
IFF
|
+$171M |
| 5 |
Principal Financial Group
PFG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$714M |
| 2 |
IBM
IBM
|
+$395M |
| 3 |
Cisco
CSCO
|
+$303M |
| 4 |
Procter & Gamble
PG
|
+$290M |
| 5 |
Macy's
M
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.6% |
| 2 | Financials | 14.73% |
| 3 | Healthcare | 12.36% |
| 4 | Industrials | 10.02% |
| 5 | Consumer Discretionary | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLBK
3351
DELISTED
Old Line Bancshares, Inc.
OLBK
| $624K | ﹤0.01% |
26,026
+10,102
| +63% | +$217K |
|
3352
Pan American Silver
PAAS
$19.9B
| $623K | ﹤0.01% |
41,310
-4,333
| -9% | -$69.8K |
|
|
MYOK
3353
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $623K | ﹤0.01% |
48,136
+18,146
| +61% | +$280K |
|
3354
Lindblad Expeditions
LIND
$2.26B
| $622K | ﹤0.01% |
65,813
+11,994
| +22% | +$109K |
|
3355
Union Bankshares
UNB
$122M
| $617K | ﹤0.01% |
13,582
+6,376
| +88% | +$248K |
|
|
DLA
3356
DELISTED
Delta Apparel Inc.
DLA
| $616K | ﹤0.01% |
29,701
+10,744
| +57% | +$195K |
|
|
ENTL
3357
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $613K | ﹤0.01% |
32,323
+3,122
| +11% | +$59.9K |
|
3358
AppFolio
APPF
$7.22B
| $612K | ﹤0.01% |
25,649
+1,172
| +5% | +$24.4K |
|
|
RXDX
3359
DELISTED
Ignyta, Inc.
RXDX
| $612K | ﹤0.01% |
115,454
+21,820
| +23% | +$127K |
|
3360
Eastern Company
EML
$154M
| $607K | ﹤0.01% |
29,029
+3,602
| +14% | +$72.2K |
|
3361
American Superconductor
AMSC
$1.53B
| $605K | ﹤0.01% |
82,085
+7,606
| +10% | +$57K |
|
3362
Silicom
SILC
$258M
| $604K | ﹤0.01% |
14,717
+4,166
| +39% | +$163K |
|
|
CRCM
3363
DELISTED
CARE.COM, INC.
CRCM
| $603K | ﹤0.01% |
70,322
+78
| +0.1% | +$686 |
|
|
SMMF
3364
DELISTED
Summit Financial Group, Inc.
SMMF
| $598K | ﹤0.01% |
21,724
+5,486
| +34% | +$129K |
|
3365
iShares US Consumer Staples ETF
IYK
$1.43B
| $597K | ﹤0.01% |
16,170
-7,734
| -32% | -$286K |
|
|
NEFF
3366
DELISTED
Neff Corporation
NEFF
| $597K | ﹤0.01% |
42,353
+13,094
| +45% | +$152K |
|
3367
Ocular Therapeutix
OCUL
$2.22B
| $595K | ﹤0.01% |
71,057
-13,142
| -16% | -$102K |
|
3368
Altimmune
ALT
$560M
| $594K | ﹤0.01% |
610
+62
| +11% | +$55.5K |
|
|
BSCH
3369
DELISTED
Guggenheim BulletShares 2017 Corporate Bond ETF
BSCH
| $593K | ﹤0.01% |
26,222
+13,774
| +111% | +$312K |
|
3370
VanEck Biotech ETF
BBH
$428M
| $591K | ﹤0.01% |
5,503
+1,001
| +22% | +$109K |
|
3371
Blue Bird Corp
BLBD
$2.05B
| $587K | ﹤0.01% |
38,015
+9,438
| +33% | +$147K |
|
3372
iShares MSCI Canada ETF
EWC
$6.55B
| $586K | ﹤0.01% |
22,444
+8,356
| +59% | +$216K |
|
3373
Mitek Systems
MITK
$853M
| $586K | ﹤0.01% |
95,261
-97,053
| -50% | -$633K |
|
|
MOCO
3374
DELISTED
Mocon Inc
MOCO
| $585K | ﹤0.01% |
+29,995
| New | +$505K |
|
3375
First Majestic Silver
AG
$9.26B
| $584K | ﹤0.01% |
76,500
+401
| +0.5% | +$3.34K |
|
Similar funds
Bank of New York Mellon's Q4 2016 Portfolio in Review
As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
- Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
- Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
- Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
- Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
- Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.
Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.